Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT06714669
Eligibility Criteria:
Inclusion Criteria:
* Scheduled for LMH;
* Age 18-80 years, BMI 18-28 kg/m2;
* American Association of Anesthesiologists（ASA）I-III;
* Child-Pugh grade A or B;
* No serious heart, brain and other important organ lesions;
* Informed and consent, and signed informed consent.
Exclusion Criteria:
* ASA IV-V or Child-Pugh C;
* Left ventricular ejection fraction (EF) \<30%;
* Implanted with temporary or permanent pacemakers;
* Organic heart disease;
* Uncontrolled hypertension, diabetes and other chronic diseases;
* Prolonged use of sedative and analgesic drugs (such as opioid analgesics, benzodiazepines, antianxiety, antidepressants, antipsychotics, etc.);
* Alcohol addiction;
* Allergic to benzodiazepines or propofol, or to any ingredient in the studied drug;
* Known history of allergy to other anesthetics; difficulty in airway and intubation during induction.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06714669
Study Brief:
Protocol Section:
NCT06714669